These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 32354798)

  • 1. Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis.
    Wei JF; Huang FY; Xiong TY; Liu Q; Chen H; Wang H; Huang H; Luo YC; Zhou X; Liu ZY; Peng Y; Xu YN; Wang B; Yang YY; Liang ZA; Lei XZ; Ge Y; Yang M; Zhang L; Zeng MQ; Yu H; Liu K; Jia YH; Prendergast BD; Li WM; Chen M
    Heart; 2020 Aug; 106(15):1154-1159. PubMed ID: 32354798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
    Guo T; Fan Y; Chen M; Wu X; Zhang L; He T; Wang H; Wan J; Wang X; Lu Z
    JAMA Cardiol; 2020 Jul; 5(7):811-818. PubMed ID: 32219356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
    Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
    Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19].
    Chen C; Chen C; Yan JT; Zhou N; Zhao JP; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):567-571. PubMed ID: 32141280
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.
    Castro VM; McCoy TH; Perlis RH
    JAMA Netw Open; 2020 Oct; 3(10):e2023934. PubMed ID: 33125498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).
    Xie Y; You Q; Wu C; Cao S; Qu G; Yan X; Han X; Wang C; Zhang H
    Circ J; 2020 Jul; 84(8):1277-1283. PubMed ID: 32536672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study.
    Matsuzawa Y; Ogawa H; Kimura K; Konishi M; Kirigaya J; Fukui K; Tsukahara K; Shimizu H; Iwabuchi K; Yamada Y; Saka K; Takeuchi I; Hirano T; Tamura K
    Hypertens Res; 2020 Nov; 43(11):1257-1266. PubMed ID: 32820236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19.
    Almeida Junior GLG; Braga F; Jorge JK; Nobre GF; Kalichsztein M; Faria PMP; Bussade B; Penna GL; Alves VO; Pereira MA; Gorgulho PC; Faria MRDSE; Drumond LE; Carpinete FBS; Neno ACLB; Neno ACA
    Arq Bras Cardiol; 2020 Oct; 115(4):660-666. PubMed ID: 33111866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
    Solé G; Salort-Campana E; Pereon Y; Stojkovic T; Wahbi K; Cintas P; Adams D; Laforet P; Tiffreau V; Desguerre I; Pisella LI; Molon A; Attarian S;
    Rev Neurol (Paris); 2020 Jun; 176(6):507-515. PubMed ID: 32354651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy.
    Sardu C; Maggi P; Messina V; Iuliano P; Sardu A; Iovinella V; Paolisso G; Marfella R
    J Am Heart Assoc; 2020 Sep; 9(17):e016948. PubMed ID: 32633594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current role of cardiac biomarkers in extra-cardiac diseases in children.
    Rodriguez-Gonzalez M; A Perez-Reviriego A; Castellano-Martinez A
    Biomark Med; 2020 Sep; 14(13):1183-1187. PubMed ID: 33021387
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.
    Raad M; Dabbagh M; Gorgis S; Yan J; Chehab O; Dagher C; Jamoor K; Hussein IH; Cook B; Van Harn M; Singh G; McCord J; Parikh S
    Am J Cardiol; 2020 Oct; 133():154-161. PubMed ID: 32829913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.